剂量,价值和亲和力对TfR介导的大脑传递 in vivo的影响
Gillian Bonvicini1,2, Sunitha Singh1, Lisa Sandersjöö1
1BioArctic AB, Warfvinges Väg 35, 112 51, Stockholm, Sweden.
Fluids and barriers of the CNS
|April 8, 2025
概括
通过转移林受体 (TfR) 调解,大脑对蛋白质结构的吸收取决于抗体的价值和亲和力,影响因剂量而异. 较低剂量有利于亲和力,而较高剂量有利于性,以获得最佳的TfR介导的大脑传递.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
背景情况:
- 对转移素受体 (TfR) 的单价结合被认为是通过血脑屏障传递高剂量的蛋白质的最佳方式.
- 有证据表明,这可能不适用于较低的诊断剂量.
- 价值和亲和力对TfR介导的大脑输送的独立影响尚不清楚.
研究的目的:
- 评估价值和亲和力对TfR介导的大脑输送的独立影响.
- 为了比较单价抗体和双价抗体,在不同剂量下具有相似的亲和力.
主要方法:
- 产生了8D3抗体的亲和性变体 (单价和双价格式),与小鼠TfR (mTfR) 具有相似的明显亲和性.
- 放射性标记抗体,并以低剂量和高剂量注射给野生型小鼠.
- 在注射后4小时,在大脑,血液和外周器官中测量生物分布.
主要成果:
- 对所有抗体来说,低剂量与高剂量相比,大脑和组织吸收率更高.
- 在低剂量,更高的表面亲和力,双价抗体显示大脑吸收更大.
- 在高剂量时,单价抗体的脑吸收率高于双价抗体.
结论:
- 大脑吸收受价值和明显亲和力以剂量依赖的方式影响.
- 在低剂量时,明显的亲和力更为关键,而高剂量时,价值性更为重要.
- 剂量和应用是设计TfR介导的大脑输送结构的关键考虑因素.
相关概念视频
Factors Affecting Drug Response: Overview
1.7K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.7K
Drugs Affecting Neurotransmitter Release or Uptake
886
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
886
Drug Delivery: Parenteral Route
337
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
337
Dose-Response Relationship: Overview
2.8K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
2.8K
Tissue-Drug Binding: Localization of Drugs and its Significance
49
Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
49
Desensitization and Tachyphylaxis
1.4K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.4K
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)

